28 studies found for:    "Typhoid fever"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Understanding Typhoid Disease After Vaccination
Conditions: Typhoid Fever;   Enteric Fever;   Typhoid
Interventions: Biological: Vaccine placebo (excipients only);   Biological: Ty21a;   Biological: M10ZH09 vaccine
2 Active, not recruiting Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever
Conditions: Enteric Fever;   Typhoid Fever
Interventions: Drug: Ceftriaxone;   Drug: Gatifloxacin
3 Completed
Has Results
Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants
Condition: Typhoid Fever
Interventions: Biological: Vi-rEPA conjugate vaccine for typhoid fever;   Biological: Hib-TT;   Biological: DTP
4 Completed Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
Condition: Typhoid Fever
Intervention: Biological: Ty800 (Salmonella typhi) Oral Vaccine
5 Completed
Has Results
Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects
Conditions: Salmonella Infections;   Typhoid Fever;   Bacterial Infections
Intervention: Biological: Typhoid Vi polysaccharide
6 Completed Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A vaccine
7 Recruiting Typhoid Fever: Combined vs. Single Antibiotic Therapy
Condition: Typhoid Fever
Interventions: Drug: ceftriaxone;   Drug: ceftriaxone and azithromycin;   Drug: azithromycin;   Drug: azithromycin and cefixime
8 Completed Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Meningococcal A (control)
9 Completed Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A (control)
10 Completed Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A vaccine
11 Completed Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults
Condition: Typhoid
Interventions: Biological: M01ZH09;   Other: Placebo
12 Not yet recruiting Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study
Conditions: Typhoid Fever;   Paratyphoid Fever
Interventions: Biological: Salmonella Typhi;   Biological: Salmonella Paratyphi
13 Completed CVD 909 Vi Prime Boost Study
Condition: Typhoid Fever
Interventions: Biological: CVD 909;   Drug: Placebo;   Biological: Vi Polysaccharide
14 Completed TY800 Dose Escalation (Typhoid)
Condition: Typhoid and Paratyphoid Fevers
Interventions: Biological: Ty800;   Drug: Placebo
15 Completed Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
Conditions: Hepatitis B;   Typhoid;   Hepatitis A
Intervention: Biological: Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix
16 Completed Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine
Condition: Typhoid Fever
Intervention: Drug: BB IND 6989
17 Completed Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age
Condition: Typhoid Fever
Intervention:
18 Completed
Has Results
Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)
Condition: Typhoid Fever
Interventions: Biological: NVGH Vi-CRM197 12.5 mcg;   Biological: NVGH Vi-CRM197 5.0 mcg;   Biological: NVGH Vi-CRM197 1.25 mcg;   Biological: Vi-polysaccharide vaccine
19 Completed
Has Results
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)
Condition: Typhoid Fever
Interventions: Biological: Typherix;   Biological: NVGH Vi-CRM197
20 Completed
Has Results
Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults
Condition: Typhoid Fever
Intervention: Biological: NVGH Vi-CRM197

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
Indicates status has not been verified in more than two years